1. P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL. (23rd June 2022) Authors: Durán, C.; Martín Cortázar, C.; Ferreras, C.; Navarro Zapata, A.; Clares Villa, L.; Al-akioui, K.; Escuredo, A.; Pernas, A.; Galán, V.; Bueno, D.; Sisinni, L.; Pérez Martínez, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE). (September 2021) Authors: Pérez-Martínez, A.; Mora-Rillo, M.; Ferreras, C.; Guerra-García, P.; Pascual-Miguel, B.; Mestre-Durán, C.; Borobia, A.M.; Carcas, A.J.; Queiruga-Parada, J.; García, I.; Sánchez-Zapardiel, E.; Gasior, M.; De Paz, R.; Marcos, A.; Vicario, J.L.; Balas, A.; Moreno, M.A.; Eguizabal, C.; Solano, C.; Ar... Journal: EClinicalMedicine Issue: Volume 39(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Use of standard formulations in pediatric home parenteral nutrition – the experience of a portuguese center during the COVID-19 pandemic. (December 2020) Authors: Ferreira, M.; Guerra, P.; Ferreras, C.; Espinheira, M.C.; Trindade, E.; Amil Dias, J. Journal: Clinical nutrition ESPEN Issue: Volume 40(2020) Page Start: 574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗